Navigation Links
Earley & Associates Offers Two-Part Webinar Series on Challenges and Solutions to Digitization in Healthcare
Date:5/3/2011

STOW, Mass., May 3, 2011 /PRNewswire/ -- Healthcare executives hold high expectations that information technology will reduce the cost of healthcare.  Many obstacles exist to digitization, however.  Earley & Associates, the nation's foremost information management and taxonomy consulting firm, is hosting a two-part webinar series titled Digitization of the Healthcare Industry Part 1 - Core Drivers and Obstacles to Adoption on Wednesday, May 4 from 1-2 p.m. EDT and Digitization of the Healthcare Industry Part 2 - Data Integration Challenges and Approaches on Wednesday, May 18 from 1-2 p.m. EDT.  The sessions will be led by Dr. Christian Reich, Program Manager at the Observational Medical Outcomes Partnership, an FDA-led NIH/PhRMA partnership.

(Logo: http://photos.prnewswire.com/prnh/20110503/NE94729LOGO)

"With the current models and drivers, we are on a path to health care costs increasing up to 35% of gross domestic product by 2050," says Reich, who will lead the webinar along with Seth Maislin.  "This means that one third of the entire economy will be healthcare-related, which is clearly unsustainable.  Information technology can solve many of the problems around the cost of healthcare, however numerous obstacles exist."

Reich will discuss the role that taxonomies and information science approaches will play in addressing: clinical trial automation, post marketing drug surveillance, benefit-risk analysis and comparative effectiveness of treatments.

Dr. Reich, Senior Consultant at Earley & Associates, is Program Manager at the Observational Medical Outcomes Partnership, a public-private research project between PhRMA and academic research institutions managed by the Foundation for the NIH and chaired by the FDA.  Reich is responsible for the technical inf
'/>"/>

SOURCE Earley & Associates
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
2. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
3. Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
4. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
5. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
6. The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
7. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
8. "Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart
9. Riverock Technologies Helps Misukanis & Odden Eliminate Task Management Obstacles
10. Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
11. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... and RARITAN, N.J. , May ... open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial ... human anti-CD38 monoclonal antibody – achieved an overall ... 20.8-38.9), as assessed by an independent review committee, ... ORR was consistent among the pre-specified subgroups based ...
(Date:5/29/2015)... Norway , May 29, 2015 ... biopharmaceutical company, today announces that an abstract on the ... molecule inhibitor of the Axl receptor tyrosine kinase, and ... at BerGenBio, has been published in conjunction with the ... in Chicago , May 29 - ...
(Date:5/29/2015)... Market Publishers Ltd and Shanghai ... partnership agreement for quality market research promotion on ... sell research reports worked out by Chem-Report. , ... upon the agreement: “Chem-Report is a Chinese company ... chemical markets on global and country levels. The ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences ® ... the promise of precision medicine, today announced the ... the clinical utility of Caris Molecular Intelligence ® ... in helping to identify targeted treatment options for ... of the studies, results of which are to ...
Breaking Biology Technology:Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6
... Cynvec LLC, a privately held biotechnology company focused ... ability of the sindbis viral vector, today announced that ... a presentation titled "Cynvec: Breakthrough Oncolytic Viral Vector Therapy ... on Biotechnology and Pharmaceutical Industry. Mr. Stonebanks, presentation ...
... Pharmaceuticals, a pioneer in the development of novel products ... disease, announced that it has promoted F. Stephen Laroux, ... inflammatory diseases, effective immediately. Dr. Laroux joined the company ... team of Cequent researchers developing drug candidates using Cequent,s ...
... LLC announced today that it has issued an Executive Informational ... full 56-page report can be found at www.crystalra.com ... Company") is a development-stage biotechnology company focused on the discovery ... inactive precursor of a drug that is converted into its ...
Cached Biology Technology:Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 2Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc. 3
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
(Date:4/13/2015)... NEW YORK , April 13, 2015 /PRNewswire/ ... study by TechSci Research, "Global Biometrics Market Forecast & ... to register a CAGR of around 14% till ... various governments for large scale implementation and review ... technology and launch of new products with greater ...
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... catch more than a cold from certain viruses. Some ... their insides to soup - without harming beneficial insects ... environmentally friendly means of biological crop protection worldwide. The ... has been controlled in European orchards for years with ...
... of the worlds worst pollution problems of the 1970s and ... Europe and North America. In Wales, more than 12,000 ... stream insects and river birds such as the dipper. ... Europe to clean up acid pollutants from power generation and ...
... States participating in the GMES Programme approved the transition ... Component Programme. Oversubscription of the programme by the ... with oversubscription to phase 2 of 116%, giving a ... the programme will allow ESA to confirm the development ...
Cached Biology News:Surprise in the organic orchard -- a healthier worm in the apple 2Recovery from acid rain 'much slower than expected' 2
... Rabbit polyclonal to MLF1 Interacting ... for all tested applications). ... corresponding to amino acids 73-83 of ... Entrez Gene ID: 359815 ...
... Nuclease is a genetically engineered endonuclease. This ... and RNA while having no proteolytic activity. ... of conditions and possesses an exceptionally high ... acids from recombinant proteins, its use enables ...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Rice microRNA Microarray ...
Biology Products: